No Evidence of Moderated Impulsivity Following Administration of the IMPase Inhibitor Ebselen in Healthy Adults
Human Psychopharmacology: Clinical and Experimental · 2026-05 · 41 (3)
DOI: 10.1002/hup.70040 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, online erschienen am 21.04.2026. Verfasst von Matthew P G John und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology and Sports Science, Bangor University, Bangor, Gwynedd, UK. Hauptthemen laut MEDLINE: Enzyme Inhibitors, Impulsive Behavior, Isoindoles, Organoselenium Compounds. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Objective
Impulsivity is a transdiagnostic risk factor for numerous health morbidities and is strongly associated with early relapse and poor treatment outcomes in addictions and mood‐disorders. Lithium carbonate can be helpful in moderating the impulsive behaviors associated with mania, possibly mediated by reduced myo ‐inositol activity following inhibition of the enzyme inositol monophosphatase (IMPase). We tested the hypothesis that impulsivity—as motor disinhibition, decisions without adequate information, and stronger preferences for small immediate rewards over larger later rewards—can be moderated by the IMPase inhibitor ebselen in healthy adult volunteers.
Methods
One hundred and thirty healthy adults completed a between‐subjects, double‐blind, placebo‐controlled protocol. Over 2 days, participants received a previously validated dose of 1800 mg of ebselen or placebo before completing tests of impulsivity and decision‐making.
Results
There were no substantive changes in any measure of impulsivity following treatment with ebselen compared with placebo. Neither was there any convincing evidence of stronger treatment effects in high‐trait impulsive participants compared with low‐trait participants.
Conclusion
These results fail to replicate findings that ebselen administration moderates validated measures of impulsivity in healthy adults, at least at doses shown to reduce myo ‐inositol within the medial prefrontal cortex and produce changes in emotional processing and reward‐based learning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Psychology and Sports Science, Bangor University, Bangor, Gwynedd, UK.
- Mental Health and Learning Disability Division, Ysbyty Gwynedd, Penrhosgarnedd, Bangor, UK.
- Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
- Oxford Health NHS Foundation Trust, Oxford, UK.
- Department of Pharmacology, University of Oxford, Oxford, UK.
ORCID-Profile: Matthew P G John, Phillip J Cowen, Trevor Sharp, Robert D Rogers
Förderung
- Medical Research Council
Zitieren
APA
John, M. P. G., Earnshaw, L., Shankar, N. G., Raja, J. S., Davies, T. J., Cowen, P. J., Sharp, T., Salmoiraghi, A., & Rogers, R. D. (2026). No Evidence of Moderated Impulsivity Following Administration of the IMPase Inhibitor Ebselen in Healthy Adults. Human Psychopharmacology: Clinical and Experimental, 41(3). https://doi.org/10.1002/hup.70040
Vancouver
John MPG, Earnshaw L, Shankar NG, Raja JS, Davies TJ, Cowen PJ, et al. No Evidence of Moderated Impulsivity Following Administration of the IMPase Inhibitor Ebselen in Healthy Adults. Human Psychopharmacology: Clinical and Experimental. 2026;41(3). doi:10.1002/hup.70040
BibTeX
@article{John2026,
author = {John, Matthew P G and Earnshaw, Luke and Shankar, Nikhil Gauri and Raja, Jawad Sultan and Davies, Timothy J and Cowen, Phillip J and Sharp, Trevor and Salmoiraghi, Alberto and Rogers, Robert D},
title = {No Evidence of Moderated Impulsivity Following Administration of the IMPase Inhibitor Ebselen in Healthy Adults},
journal = {Human Psychopharmacology: Clinical and Experimental},
year = {2026},
volume = {41},
number = {3},
doi = {10.1002/hup.70040}
}
EUVIMED